Cancer Screening

Our proprietary miRNA technology detects cancer at its earliest, most treatable stages. With minimally invasive test and accurate insights, our tests enable patients to act sooner.

A pioneering blood test for the early detection of gastric (stomach) cancer.

LUNGClear

A minimally invasive blood test designed to identify lung cancer at an early stage.

Cancer Treatment Selection

We leverage advanced Next-Generation Sequencing (NGS) technology to empower patients in personalised cancer treatment selection.

APEX Tissue

A Targeted 58-Gene Profiling Test

COMPASS Tissue

A Comprehensive 1021-Gene Profiling Test

Careers

Be part of the team delivering world-leading multi-cancer early detection.

Join the Mirxes Team

Be part of the team delivering world-leading multi-cancer early detection.

Mirxes is a Singapore-headquartered biotechnology company that translates research discoveries to deliver world-leading multi-cancer early detection. We are Asia-centered, starting with Southeast Asia, and have global ambitions. We have research, development, manufacturing, and clinical diagnostic operations in Singapore, USA, Japan, and China.

Our versatile platform technology and capabilities have broad applications in the discovery of biomarkers and diagnosis of diseases. We started with cancer, but are also addressing unmet clinical needs in cardiovascular, metabolic, and infectious diseases.

Work Where You're Inspired